Current management of unusual genitourinary cancers. Part 2: Urethral cancer.
Often overshadowed by more common genitourinary cancers, such as prostate, testicular, and kidney cancers, penile and urethral cancers nonetheless represent difficult treatment challenges for the clinician. The management of these cancers is slowly evolving. In the past, surgery, often extensive, was the treatment of choice. Recently, however, radiation and chemotherapy have begun to play larger roles as initial therapies, with surgery being reserved for salvage. With these modalities in their treatment armamentarium, oncologists may now be able to spare patients some of the physical and psychological sequelae that often follow surgical intervention without compromising local control and survival. Part 1 of this two-part article, published in last month's issue, dealt with cancer of the penis. This second part focuses on cancer of the urethra in both females and males.
Krieg
R
R
Department of Radiation Oncology, University of California, San Francisco, USA.
Hoffman
R
R
D005260:Female; D006801:Humans; D008297:Male; D015996:Survival Rate; D014523:Urethral Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*